T-Cell Therapy for Advanced Breast Cancer

NCT02792114 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

186

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer
Metastatic HER2-negative Breast

Interventions

DRUG: Cyclophosphamide
BIOLOGICAL: Mesothelin-targeted T cells
DRUG: AP1903

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]